STAGED ABDOMINAL REPAIR COMPARES FAVORABLY WITH CONVENTIONAL OPERATIVE THERAPY FOR INTRAABDOMINAL INFECTIONS WHEN ADJUSTING FOR PROGNOSTIC FACTORS WITH A LOGISTIC MODEL
Dh. Wittmann et al., STAGED ABDOMINAL REPAIR COMPARES FAVORABLY WITH CONVENTIONAL OPERATIVE THERAPY FOR INTRAABDOMINAL INFECTIONS WHEN ADJUSTING FOR PROGNOSTIC FACTORS WITH A LOGISTIC MODEL, Theoretical surgery, 9(4), 1994, pp. 201-207
Staged abdominal repair (STAR) is a newly developed operative approach
for the treatment of diffuse peritonitis. It demands a commitment at
the first laparotomy for multiple relaparotomies scheduled at 24-h int
ervals. STAR reverses the pathophysiological impact of increased intra
-abdominal pressure on pulmonary, renal, cardiovascular, and liver fun
ction and peritoneal blood flow. If required, prosthetic devices may b
e used to bridge any fascial gap and to accommodate the edematous peri
toneum and distended bowels. This minimizes fistula formation and dete
rs abdominal fascial retraction, while permitting definitive abdominal
fascial closure without evisceration and hernia formation. Since pros
pective controlled studies are difficult to perform and are therefore
not available, we provide another model to test improvement in outcome
following STAR. We stratified 95 patients treated by STAR according t
o the APACHE-II score and compared this series with 260 patients with
intra-abdominal infections treated by conventional operative managemen
t (NON-STAR) and entered into a prospective multicenter observation st
udy. Pearson chi-square analysis revealed no significant difference (P
= 0.624) between mortality of STAR (24.2%) and NON-STAR (21.8%). The
Mann-Whitney U-Test, however, showed a significant difference (P < 0.0
01) between the APACHE-II scores of STAR and NON-STAR, indicating that
there might be a difference in mortality when comparing patients at e
qual mortality risk. To adjust for the significant differences in prog
nostic factors, we used a logistic model with APACHE-II scores as depe
ndent variables and introduced a therapeutic categorical variable pair
(STAR and NON-STAR) to examine the difference of their respective con
tribution to the event rate. A significant difference in the mortality
was confirmed in favor of STAR (P = 0.0179), and the logistic equatio
n is given by [Log p/1-p -4.14 + (0.193() APACHE-II) + (0.4121(*) OPE
RATION)], where OPERATION is +1 for NON-STAR patients and -1 for STAR
patients. We conclude that STAR is superior to conventional operative
therapy for advanced suppurative peritonitis.